BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24729464)

  • 21. Synthesis and biological evaluation of a novel series of 6,8-dibromo-4(3H)quinazolinone derivatives as anticancer agents.
    Ahmed MF; Youns M
    Arch Pharm (Weinheim); 2013 Aug; 346(8):610-7. PubMed ID: 23873839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and anticancer activities evaluation of novel 5H-dibenzo[b,e]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units.
    He X; Li XY; Liang JW; Cao C; Li S; Zhang TJ; Meng FH
    Bioorg Med Chem Lett; 2018 Mar; 28(5):847-852. PubMed ID: 29456106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative.
    Shamroukh AH; El-Shahat M; Drabowicz J; Ali MM; Rashad AE; Ali HS
    Eur J Med Chem; 2013 Nov; 69():521-6. PubMed ID: 24095746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
    Kamal A; Vijaya Bharathi E; Janaki Ramaiah M; Dastagiri D; Surendranadha Reddy J; Viswanath A; Sultana F; Pushpavalli SN; Pal-Bhadra M; Srivastava HK; Narahari Sastry G; Juvekar A; Sen S; Zingde S
    Bioorg Med Chem; 2010 Jan; 18(2):526-42. PubMed ID: 20031423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and anticancer activity of 1-acyl-3-amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives.
    Bai XG; Yu DK; Wang JX; Zhang H; He HW; Shao RG; Li XM; Wang YC
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6947-51. PubMed ID: 23036956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors.
    Park SJ; Kim E; Yoo M; Lee JY; Park CH; Hwang JY; Ha JD
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4399-4404. PubMed ID: 28827110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines.
    Tangeda SJ; Garlapati A
    Eur J Med Chem; 2010 Apr; 45(4):1453-8. PubMed ID: 20163895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and molecular docking study of 3H-imidazole[4,5-c]pyridine derivatives as CDK2 inhibitors.
    Wu YZ; Ying HZ; Xu L; Cheng G; Chen J; Hu YZ; Liu T; Dong XW
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1700381. PubMed ID: 29708285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of novel pyrrolo[2,3-a]carbazoles: 7-Chloro-2-oxo-3a-(2'-oxo-2',3'-dihydro-1'H-indol-3'-yl)-2,3,3a,4,5,10-hexahydro-pyrrolo[3,2-a]carbazole-1-carbonitrile as an efficient anticancer agent.
    Sathiyachandran P; Manogaran P; Nesterov VN; Padma VV; Rajendra Prasad KJ
    Eur J Med Chem; 2018 Apr; 150():851-863. PubMed ID: 29597168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles with anti-breast cancer properties.
    Soares MI; Brito AF; Laranjo M; Paixão JA; Botelho MF; Pinho e Melo TM
    Eur J Med Chem; 2013 Feb; 60():254-62. PubMed ID: 23313634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.
    Santos K; Laranjo M; Abrantes AM; Brito AF; Gonçalves C; Sarmento Ribeiro AB; Botelho MF; Soares MI; Oliveira AS; Pinho e Melo TM
    Eur J Med Chem; 2014 May; 79():273-81. PubMed ID: 24747064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.
    Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM
    Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity.
    Szalóki G; Pantzou A; Prousis KC; Mavrofrydi O; Papazafiri P; Calogeropoulou T
    Bioorg Med Chem; 2014 Dec; 22(24):6980-8. PubMed ID: 25456391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New potent and selective inhibitor of Pim-1/3 protein kinases sensitizes human colon carcinoma cells to doxorubicin.
    Moreau P; Dezhenkova LG; Anizon F; Nauton L; Thery V; Liang S; Kaluzhny DN; Shtil AA
    Anticancer Agents Med Chem; 2014; 14(9):1228-36. PubMed ID: 25175798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
    Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
    Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
    Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
    Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
    Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
    Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
    Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.